# Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

> **NCT03066466** · PHASE3 · WITHDRAWN · sponsor: **Loyola University**

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphocytic Leukemia
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Methotrexate
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT03066466
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-12-10
- **Primary completion:** 2020-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants were enrolled
- **Last updated:** 2021-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03066466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03066466, "Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03066466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*